Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials
Satoshi Miyashita, Toshiki Kuno, Hisato Takagi, Takehiro Sugiyama, Tomo Ando, Nelson Valentin, Yuichi J. Shimada, Masaki Kodaira, Yohei Numasawa, Yumiko Kanei, Sripal Bangalore
Topics & Concepts
CanagliflozinMedicineEmpagliflozinDapagliflozinAmputationMeta-analysisRandomized controlled trialInternal medicinePlaceboHazard ratioSubgroup analysisDiabetes mellitusAdverse effectRelative riskLower riskConfidence intervalSurgeryType 2 diabetesEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerGastric Cancer Management and Outcomes